Punch & Associates Investment Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-360
Closed -$334K 242
2020
Q4
$334K Hold
360
0.02% 203
2020
Q3
$370K Hold
360
0.03% 199
2020
Q2
$365K Hold
360
0.03% 196
2020
Q1
$313K Hold
360
0.04% 189
2019
Q4
$386K Hold
360
0.03% 187
2019
Q3
$333K Hold
360
0.03% 192
2019
Q2
$407K Hold
360
0.03% 182
2019
Q1
$489K Hold
360
0.04% 178
2018
Q4
$417K Hold
360
0.04% 190
2018
Q3
$547K Hold
360
0.04% 182
2018
Q2
$563K Hold
360
0.05% 179
2018
Q1
$416K Sell
360
-443
-55% -$583K 0.04% 174
2017
Q4
$952K Hold
803
0.08% 175
2017
Q3
$1.08M Sell
803
-465
-37% -$490K 0.1% 174
2017
Q2
$1.02M Sell
1,268
-120
-9% -$83.6K 0.1% 176
2017
Q1
$855K Sell
1,388
-120
-8% -$73.1K 0.08% 179
2016
Q4
$807K Hold
1,508
0.08% 176
2016
Q3
$780K Hold
1,508
0.08% 173
2016
Q2
$619K Hold
1,508
0.07% 171
2016
Q1
$803K Sell
1,508
-89
-6% -$44.4K 0.1% 160
2015
Q4
$1.22M Hold
1,597
0.15% 160
2015
Q3
$875K Hold
1,597
0.12% 171
2015
Q2
$938K Buy
+1,597
New +$929K 0.12% 168

Other funds holding KYNB

Punch & Associates Investment Management's KYNB Position: Q1 2021 in Review

Punch & Associates Investment Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 360 shares — an estimated $334K sold.

Punch & Associates Investment Management first reported a position in KYNB in Q2 2015 and held it in 23 quarters. The position peaked at $1.22M in Q4 2015. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Punch & Associates Investment Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Punch & Associates Investment Management sold 360 Kyntra Bio shares in Q1 2021, an estimated $334K.
  • Punch & Associates Investment Management first reported a position in Kyntra Bio in Q2 2015 and held it in 23 quarters.
  • Punch & Associates Investment Management's Kyntra Bio position peaked at $1.22M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Punch & Associates Investment Management's 13F filing for Q1 2021, filed 18 May 2021.